 CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, June 01, 2021 GLOBE NEWSWIRE -- Centogene N.V. Nasdaq: CNTG, a commercial-stage company focused on generating data-driven insights to diagnose, understand, and treat rare diseases, today announced the launch of NEW CentoXome, an enhanced next-generation sequencing-based assay. 